Cubist Systematic Strategies, LLC Point Biopharma Global Inc. Transaction History

Cubist Systematic Strategies, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$6.86 - $10.86 $797,646 - $1.26 Million	116,275 Added 617.01%	135,120 $1.22 Million
Q1 2023 May 15, 2023	SELL	$6.78 - $8.1 $236,357 - $282,374	-34,861 Reduced 64.91%	18,845 $137,000
Q4 2022 Feb 14, 2023	SELL	$5.72 - $9.78 $196,642 - $336,216	-34,378 Reduced 39.03%	53,706 $391,000
Q3 2022 Nov 14, 2022	BUY	$7.24 - $10.31 $626,144 - $891,650	86,484 Added 5405.25%	88,084 $681,000
Q2 2022 Aug 15, 2022	SELL	$5.6 - $9.5 $180,857 - $306,812	-32,296 Reduced 95.28%	1,600 $11,000
Q1 2022 May 16, 2022	BUY	$5.46 - $8.13 $185,072 - $275,574	33,896 New	33,896 $270,000
Q4 2021 Feb 14, 2022	SELL	$4.83 - $9.75 $17,566 - $35,460	-3,637 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$7.42 - $11.26 $26,986 - $40,952	3,637 New	3,637 $28,000

20K

Ticker PNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 104,025,000
Description
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.